- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 12.49M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.95M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $7.54M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $6.88M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $7.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $31.33M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $31.95M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $48.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $52.5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $74.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $78.81M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $19.83M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $152.29M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $159.53M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.16M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $340K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.08M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $99.32M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $96.28M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.06 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $5.42M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | $662K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $492K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $13.08M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $16.75M |